Abstract: Disclosed is a method and system for playing content using a smart signage device. An embodiment of a content playing method using a smart signage device according to the present disclosure may include: checking coupling or separation of a smart signage device; determining a screen group in association with the coupling or separation of the smart signage device; generating content suitable for the screen group; determining mash-up content assigned to at least one smart signage device included in the screen group; and plying the mash-up content assigned to the at least one smart signage device.

Abstract: The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same.

Abstract: The present invention refers to the injectable hyaluronic acid composition which is crosslinked viscoelastic hyaluronic acid gel comprising DNA fractions. More particularly, it refers to the injectable hyaluronic acid composition comprising a hyaluronic acid composition crosslinked in the basic conditions with the degree of crosslinking between 0.1 and 200%, which is mixed with the DNA fractions of 0.1 to 50 wt %. The DNA fractions are selected, for example, from polynucleotide (PN) and polydeoxyribonucleotide (PDRN). The composition used for cosmetic purposes or therapeutic purposes, have improved viscoelastic rheological properties and enzyme resistance.

Abstract: Provided is a novel compound capable of effectively preventing and treating immune diseases and a use thereof. The novel compound of the present subject matter has effects of inhibiting the production of inflammatory cytokines, increasing the activity of regulatory T cells having immunoregulatory functions, inhibiting the production of auto-antibodies to regulate excessive immune responses, and inhibiting the differentiation of osteoclasts, and thus can be used for treating immune diseases, such as autoimmune disease, inflammatory disease, and transplant rejection diseases, which are caused by abnormal regulation of various kinds of immune response.

Abstract: A bidet apparatus according to an embodiment of the present invention may comprise: a nozzle case provided inside of a frame; a nozzle, provided in the nozzle case so as to be movable forward and backward, having a discharge outlet at one end thereof; and a drier, provided inside of the frame, for spraying air toward the discharge outlet. As such, a user can dry a nozzle discharge cutlet by only a simple button operation.

Abstract: The present invention provides a semi-automatic pressure type water softener including: an ionic resin tank (100) provided with an ionic resin; a regeneration vessel (200), into which a regenerant is introduced and which generates reclaimed water filled with the ionic resin; a drain valve (293) provided in the regeneration vessel (200) and configured to discharge residual water to the outside; a water inlet part (400) configured to selectively supply raw water to the ionic resin tank (100) and the regeneration vessel (200); and a timer/ceramic disk conversion valve (300) configured to select any one of a water softening mode, a raw water mode, and a regeneration mode to convert a passage between any two of the water inlet part (400), the ionic resin tank (100), and the regeneration tank (200), wherein the water softener is in the regeneration mode, any one of a first mode and a second mode is selected according to a preset method, wherein the first mode is operated for a preset period of time by the timer/cer

Abstract: The present invention relates to a novel compound capable of effectively preventing and treating immune diseases and a use thereof.

Abstract: A screen position sensing method in a multi display system, a content configuring method, a watermark image generating method for sensing a screen position, a server, and a display terminal are provided. A screen position sensing method in a multi display system performed by a sensing server may include receiving identification information of display terminals from a display server, receiving an image output by each of the display terminals from a camera, and determining a screen position of each of the display terminals based on a watermark included in the image of the display terminals and the received identification information.

Abstract: Various embodiments of the present disclosure relate to a device and method for reducing current consumption in an electronic device. The electronic device may include a communication interface that transmits and receives a signal; and a processor that configures a multi-hop network with at least one other electronic device, and changes the transmission period of a message for a path management of the multi-hop network based on whether the multi-hop network configuration has been changed. Other embodiments are also possible.

Abstract: Provided is a display control method including: obtaining a first input of a user regarding a first region displayed on a display unit; activating an input reference object in the first region based on the first input; displaying an interface for manipulating the input reference object in a second region on the display unit based on the first input; obtaining a second input of the user regarding the interface; and changing a location of the input reference object in the first region based on the second input.

Abstract: A method for providing telepresence by employing avatars is provided. The method includes steps of: (a) a corresponding location searching part determining a location in a first space where an avatar Y? corresponding to a human Y in a second space will be placed, if a change of a location of the human Y in the second space is detected from an initial state, by referring to (i) information on the first space and the second space and (ii) information on locations of the humans X and Y, and the avatar X? in the first and the second spaces; and (b) an avatar motion creating part creating a motion of the avatar Y? by referring to information on the determined location where the avatar Y? will be placed.

Abstract: The present invention relates to a biguanide derivative compound capable of effectively preventing and treating immune diseases. The biguanide-based derivative compound according to the present invention inhibits the generation of IL-17 and TNF-?, which are inflammatory cytokines, increases the activity of regulatory T cells having an immunomodulatory function, and exhibits excellent therapeutic effects in animal models of immune diseases. Accordingly, the biguanide-based derivative compound can be usefully used as an immunosuppressant or a pharmaceutical composition capable of preventing or treating various immune diseases, such as autoimmune diseases, inflammatory diseases, and transplant rejection, caused by the dysregulation of immune responses.

Abstract: A novel anti-vascular endothelial growth factor (VEGF) antibody having a strong binding affinity for VEGF and capable of inhibiting in vivo tumor growth and a composition for the treatment of cancer, containing the same. The antibody shows a remarkable binding property to human and mouse VEGF, suppresses the proliferation and permeability of a human umbilical vein endothelial cell (HUVEC) and inhibits tumor growth, and thus can be useful as an antibody for the treatment of cancer.

Abstract: Disclosed is a method for providing a rigging tool. The method for providing a rigging tool includes receiving an input character, generating a basic rigging at the input character by using a skeleton extraction technique and a skinning weight technique, and providing a skeleton correction function and a skinning weight correction function on the basis of the generated basic rigging.

Abstract: This invention relates to a stable liquid formulation comprising hyaluronidase and a stabilizer for hyaluronidase and more particularly, to a stable liquid formulation by the addition of the stabilizer to the hyaluronidase.

Abstract: This invention relates to a stable hyaluronidase liquid formulation comprising a hyaluronidase and a stabilizer for hyaluronidase. In particular, the hyaluronidase has a purity of 95% or more and the specific activity of 70,000 IU/mg or more, and the stabilizer for hyaluronidase contains a buffering agent in order to provide pH of 4.0 to 6.0; 0.001 to 0.5 v/v % of a non-ionic surfactant; and 0.1 to 5 mM of a chelating agent or MgCl2. The liquid formulation has advantages in that it stably maintains its activity for a long period of time and may be easily administered than the conventional formulations.

Abstract: A semiconductor device includes a field regions in a substrate to define active regions, gate trenches including active trenches disposed across the active region and field trenches in the field regions, and word lines that fill the gate trenches and extend in a first direction. The word lines include active gate electrodes occupying the active trenches, and field gate electrodes occupying the field trenches. The bottom surface of each field gate electrode, which is disposed between active regions that are adjacent to each other and have one word line therebetween, is disposed at a higher level than the bottom surfaces of the active gate electrodes.